APO RESEARCH · REPORT
Aprotinin
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Product & engineering
Understand the product.
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Selected research
Market Analysis & Forecast
Global Aprotinin Market Analysis and Forecast 2026-2032
Market perspective
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Global Aprotinin key players include Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited, etc. Global top four manufacturers hold a share over 25%.
India is the largest market, with a share about 20%, followed by China, and North America, both have a share about 35 percent.
Read the full market overview
In terms of product, Aprotinin (From bovine lung) is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Pharmaceuticals, followed by Scientific Research and Experiment.
This report presents an overview of global market for Aprotinin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Aprotinin, also provides the sales of main regions and countries. Of the upcoming market potential for Aprotinin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aprotinin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aprotinin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aprotinin sales, projected growth trends, production technology, application and end-user industry.
Aprotinin Segment by Company
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Aprotinin Segment by Type
Aprotinin (From bovine lung)
Recombinant Aprotinin
Aprotinin Segment by Application
Pharmaceuticals
Scientific Research and Experiment
Aprotinin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprotinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aprotinin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprotinin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Aprotinin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Aprotinin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aprotinin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aprotinin (From bovine lung)
- Recombinant Aprotinin
Applications
- Pharmaceuticals
- Scientific Research and Experiment
Companies covered
- Sigma-Aldrich
- BeiJing Geyuantianrun Bio-tech
- Cayman Chemical
- Taj Pharmaceuticals Limited
- Guangdong Techpool Bio-pharma
- Dadeli
- A.S.Joshi&Company
- Enzymeking Biotechnology
- AdooQ BioScience
- ProSpec
- Yaxin Biotechnology
- AMRESCO
- PanReac AppliChem
- Runhao
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Aprotinin Market by Type
- 1.2.1 Global Aprotinin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Aprotinin (From bovine lung)
- 1.2.3 Recombinant Aprotinin
- 1.3 Aprotinin Market by Application
- 1.3.1 Global Aprotinin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Scientific Research and Experiment
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Aprotinin Market Dynamics
- 2.1 Aprotinin Industry Trends
- 2.2 Aprotinin Industry Drivers
- 2.3 Aprotinin Industry Opportunities and Challenges
- 2.4 Aprotinin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Aprotinin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Aprotinin Revenue by Region
- 3.2.1 Global Aprotinin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Aprotinin Revenue by Region (2021-2026)
- 3.2.3 Global Aprotinin Revenue by Region (2027-2032)
- 3.2.4 Global Aprotinin Revenue Market Share by Region (2021-2032)
- 3.3 Global Aprotinin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Aprotinin Sales by Region
- 3.4.1 Global Aprotinin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Aprotinin Sales by Region (2021-2026)
- 3.4.3 Global Aprotinin Sales by Region (2027-2032)
- 3.4.4 Global Aprotinin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Aprotinin Revenue by Manufacturers
- 4.1.1 Global Aprotinin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Aprotinin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Aprotinin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Aprotinin Sales by Manufacturers
- 4.2.1 Global Aprotinin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Aprotinin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Aprotinin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Aprotinin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Aprotinin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Aprotinin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Aprotinin Manufacturers, Product Type & Application
- 4.7 Global Aprotinin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Aprotinin Market CR5 and HHI
- 4.8.2 2025 Aprotinin Tier 1, Tier 2, and Tier 3
5 Aprotinin Market by Type
- 5.1 Global Aprotinin Revenue by Type
- 5.1.1 Global Aprotinin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Aprotinin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Aprotinin Revenue Market Share by Type (2021-2032)
- 5.2 Global Aprotinin Sales by Type
- 5.2.1 Global Aprotinin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Aprotinin Sales by Type (2021-2032) & (g)
- 5.2.3 Global Aprotinin Sales Market Share by Type (2021-2032)
- 5.3 Global Aprotinin Price by Type
6 Aprotinin Market by Application
- 6.1 Global Aprotinin Revenue by Application
- 6.1.1 Global Aprotinin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Aprotinin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Aprotinin Revenue Market Share by Application (2021-2032)
- 6.2 Global Aprotinin Sales by Application
- 6.2.1 Global Aprotinin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Aprotinin Sales by Application (2021-2032) & (g)
- 6.2.3 Global Aprotinin Sales Market Share by Application (2021-2032)
- 6.3 Global Aprotinin Price by Application
7 Company Profiles
- 7.1 Sigma-Aldrich
- 7.1.1 Sigma-Aldrich Company Information
- 7.1.2 Sigma-Aldrich Business Overview
- 7.1.3 Sigma-Aldrich Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sigma-Aldrich Aprotinin Product Portfolio
- 7.1.5 Sigma-Aldrich Recent Developments
- 7.2 BeiJing Geyuantianrun Bio-tech
- 7.2.1 BeiJing Geyuantianrun Bio-tech Company Information
- 7.2.2 BeiJing Geyuantianrun Bio-tech Business Overview
- 7.2.3 BeiJing Geyuantianrun Bio-tech Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 BeiJing Geyuantianrun Bio-tech Aprotinin Product Portfolio
- 7.2.5 BeiJing Geyuantianrun Bio-tech Recent Developments
- 7.3 Cayman Chemical
- 7.3.1 Cayman Chemical Company Information
- 7.3.2 Cayman Chemical Business Overview
- 7.3.3 Cayman Chemical Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Cayman Chemical Aprotinin Product Portfolio
- 7.3.5 Cayman Chemical Recent Developments
- 7.4 Taj Pharmaceuticals Limited
- 7.4.1 Taj Pharmaceuticals Limited Company Information
- 7.4.2 Taj Pharmaceuticals Limited Business Overview
- 7.4.3 Taj Pharmaceuticals Limited Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Taj Pharmaceuticals Limited Aprotinin Product Portfolio
- 7.4.5 Taj Pharmaceuticals Limited Recent Developments
- 7.5 Guangdong Techpool Bio-pharma
- 7.5.1 Guangdong Techpool Bio-pharma Company Information
- 7.5.2 Guangdong Techpool Bio-pharma Business Overview
- 7.5.3 Guangdong Techpool Bio-pharma Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Guangdong Techpool Bio-pharma Aprotinin Product Portfolio
- 7.5.5 Guangdong Techpool Bio-pharma Recent Developments
- 7.6 Dadeli
- 7.6.1 Dadeli Company Information
- 7.6.2 Dadeli Business Overview
- 7.6.3 Dadeli Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Dadeli Aprotinin Product Portfolio
- 7.6.5 Dadeli Recent Developments
- 7.7 A.S.Joshi&Company
- 7.7.1 A.S.Joshi&Company Company Information
- 7.7.2 A.S.Joshi&Company Business Overview
- 7.7.3 A.S.Joshi&Company Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 A.S.Joshi&Company Aprotinin Product Portfolio
- 7.7.5 A.S.Joshi&Company Recent Developments
- 7.8 Enzymeking Biotechnology
- 7.8.1 Enzymeking Biotechnology Company Information
- 7.8.2 Enzymeking Biotechnology Business Overview
- 7.8.3 Enzymeking Biotechnology Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Enzymeking Biotechnology Aprotinin Product Portfolio
- 7.8.5 Enzymeking Biotechnology Recent Developments
- 7.9 AdooQ BioScience
- 7.9.1 AdooQ BioScience Company Information
- 7.9.2 AdooQ BioScience Business Overview
- 7.9.3 AdooQ BioScience Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 AdooQ BioScience Aprotinin Product Portfolio
- 7.9.5 AdooQ BioScience Recent Developments
- 7.10 ProSpec
- 7.10.1 ProSpec Company Information
- 7.10.2 ProSpec Business Overview
- 7.10.3 ProSpec Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 ProSpec Aprotinin Product Portfolio
- 7.10.5 ProSpec Recent Developments
- 7.11 Yaxin Biotechnology
- 7.11.1 Yaxin Biotechnology Company Information
- 7.11.2 Yaxin Biotechnology Business Overview
- 7.11.3 Yaxin Biotechnology Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Yaxin Biotechnology Aprotinin Product Portfolio
- 7.11.5 Yaxin Biotechnology Recent Developments
- 7.12 AMRESCO
- 7.12.1 AMRESCO Company Information
- 7.12.2 AMRESCO Business Overview
- 7.12.3 AMRESCO Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 AMRESCO Aprotinin Product Portfolio
- 7.12.5 AMRESCO Recent Developments
- 7.13 PanReac AppliChem
- 7.13.1 PanReac AppliChem Company Information
- 7.13.2 PanReac AppliChem Business Overview
- 7.13.3 PanReac AppliChem Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 PanReac AppliChem Aprotinin Product Portfolio
- 7.13.5 PanReac AppliChem Recent Developments
- 7.14 Runhao
- 7.14.1 Runhao Company Information
- 7.14.2 Runhao Business Overview
- 7.14.3 Runhao Aprotinin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Runhao Aprotinin Product Portfolio
- 7.14.5 Runhao Recent Developments
8 North America
- 8.1 North America Aprotinin Market Size by Type
- 8.1.1 North America Aprotinin Revenue by Type (2021-2032)
- 8.1.2 North America Aprotinin Sales by Type (2021-2032)
- 8.1.3 North America Aprotinin Price by Type (2021-2032)
- 8.2 North America Aprotinin Market Size by Application
- 8.2.1 North America Aprotinin Revenue by Application (2021-2032)
- 8.2.2 North America Aprotinin Sales by Application (2021-2032)
- 8.2.3 North America Aprotinin Price by Application (2021-2032)
- 8.3 North America Aprotinin Market Size by Country
- 8.3.1 North America Aprotinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Aprotinin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Aprotinin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Aprotinin Market Size by Type
- 9.1.1 Europe Aprotinin Revenue by Type (2021-2032)
- 9.1.2 Europe Aprotinin Sales by Type (2021-2032)
- 9.1.3 Europe Aprotinin Price by Type (2021-2032)
- 9.2 Europe Aprotinin Market Size by Application
- 9.2.1 Europe Aprotinin Revenue by Application (2021-2032)
- 9.2.2 Europe Aprotinin Sales by Application (2021-2032)
- 9.2.3 Europe Aprotinin Price by Application (2021-2032)
- 9.3 Europe Aprotinin Market Size by Country
- 9.3.1 Europe Aprotinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Aprotinin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Aprotinin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Aprotinin Market Size by Type
- 10.1.1 China Aprotinin Revenue by Type (2021-2032)
- 10.1.2 China Aprotinin Sales by Type (2021-2032)
- 10.1.3 China Aprotinin Price by Type (2021-2032)
- 10.2 China Aprotinin Market Size by Application
- 10.2.1 China Aprotinin Revenue by Application (2021-2032)
- 10.2.2 China Aprotinin Sales by Application (2021-2032)
- 10.2.3 China Aprotinin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Aprotinin Market Size by Type
- 11.1.1 Asia Aprotinin Revenue by Type (2021-2032)
- 11.1.2 Asia Aprotinin Sales by Type (2021-2032)
- 11.1.3 Asia Aprotinin Price by Type (2021-2032)
- 11.2 Asia Aprotinin Market Size by Application
- 11.2.1 Asia Aprotinin Revenue by Application (2021-2032)
- 11.2.2 Asia Aprotinin Sales by Application (2021-2032)
- 11.2.3 Asia Aprotinin Price by Application (2021-2032)
- 11.3 Asia Aprotinin Market Size by Country
- 11.3.1 Asia Aprotinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Aprotinin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Aprotinin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Aprotinin Market Size by Type
- 12.1.1 SAMEA Aprotinin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Aprotinin Sales by Type (2021-2032)
- 12.1.3 SAMEA Aprotinin Price by Type (2021-2032)
- 12.2 SAMEA Aprotinin Market Size by Application
- 12.2.1 SAMEA Aprotinin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Aprotinin Sales by Application (2021-2032)
- 12.2.3 SAMEA Aprotinin Price by Application (2021-2032)
- 12.3 SAMEA Aprotinin Market Size by Country
- 12.3.1 SAMEA Aprotinin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Aprotinin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Aprotinin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Aprotinin Value Chain Analysis
- 13.1.1 Aprotinin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Aprotinin Production Mode & Process
- 13.2 Aprotinin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Aprotinin Distributors
- 13.2.3 Aprotinin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst